This technical brief describes Lonza's SimpliFiH Solutions--a streamlined, comprehensive service package designed for early-phase projects. Builiding our world-class expertise in bioavailability enhancement, SimpliFiH is designed to be a phase-appropriate solution in advancing drug programs to first-in-human (FIH) studies in as little as 32 weeks while reducing active-compound consumption,
risk, and complexity. To learn more, please read our technical brief.
You may also be interested in:
View our technical brief
Latest content
Latest briefing from the Knowledge Center